Literature DB >> 28763371

Proinflammatory Cytokines Mediate GPCR Dysfunction.

Maradumane L Mohan1, Neelakantan T Vasudevan, Sathyamangla V Naga Prasad.   

Abstract

Proinflammatory reaction by the body occurs acutely in response to injury that is considered primarily beneficial. However, sustained proinflammatory cytokines observed with chronic pathologies such as metabolic syndrome, cancer, and arthritis are detrimental and in many cases is a major cardiovascular risk factor. Proinflammatory cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor α (TNFα) have long been implicated in cardiovascular risk and considered to be a major underlying cause for heart failure (HF). The failure of the anti-TNFα therapy for HF indicates our elusive understanding on the dichotomous role of proinflammatory cytokines on acutely beneficial effects versus long-term deleterious effects. Despite these well-described observations, less is known about the mechanistic underpinnings of proinflammatory cytokines especially TNFα in pathogenesis of HF. Increasing evidence suggests the existence of an active cross-talk between the TNFα receptor signaling and G-protein-coupled receptors such as β-adrenergic receptor (βAR). Given that βARs are the key regulators of cardiac function, the review will discuss the current state of understanding on the role of proinflammatory cytokine TNFα in regulating βAR function.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28763371      PMCID: PMC5483210          DOI: 10.1097/FJC.0000000000000456

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  245 in total

Review 1.  Catecholamines, cardiac beta-adrenergic receptors, and heart failure.

Authors:  R J Lefkowitz; H A Rockman; W J Koch
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

2.  Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte.

Authors:  H Oral; G W Dorn; D L Mann
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

Review 3.  The role of TNFalpha and TNF receptors in obesity and insulin resistance.

Authors:  G S Hotamisligil
Journal:  J Intern Med       Date:  1999-06       Impact factor: 8.989

4.  Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha.

Authors:  Hajime Funakoshi; Toru Kubota; Yoji Machida; Natsumi Kawamura; Arthur M Feldman; Hiroyuki Tsutsui; Hiroaki Shimokawa; Akira Takeshita
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

5.  Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells.

Authors:  E Sadot; D Gurwitz; J Barg; L Behar; I Ginzburg; A Fisher
Journal:  J Neurochem       Date:  1996-02       Impact factor: 5.372

6.  Subchronic exposure of cardiomyocytes to low concentrations of tumor necrosis factor alpha attenuates the positive inotropic response not only to catecholamines but also to cardiac glycosides and high calcium concentrations.

Authors:  P Boekstegers; I Kainz; W Giehrl; W Peter; K Werdan
Journal:  Mol Cell Biochem       Date:  1996-03-23       Impact factor: 3.396

7.  G protein-coupled receptor kinase-5 attenuates atherosclerosis by regulating receptor tyrosine kinases and 7-transmembrane receptors.

Authors:  Jiao-Hui Wu; Lisheng Zhang; Alexander C Fanaroff; Xinjiang Cai; Krishn C Sharma; Leigh Brian; Sabrina T Exum; Sudha K Shenoy; Karsten Peppel; Neil J Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-17       Impact factor: 8.311

8.  Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide.

Authors:  H G Evans; M J Lewis; A M Shah
Journal:  Cardiovasc Res       Date:  1993-08       Impact factor: 10.787

9.  The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha.

Authors:  R Schulz; D L Panas; R Catena; S Moncada; P M Olley; G D Lopaschuk
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.

Authors:  Henriette Brinks; Matthieu Boucher; Erhe Gao; J Kurt Chuprun; Stéphanie Pesant; Philip W Raake; Z Maggie Huang; Xiaoliang Wang; Gang Qiu; Anna Gumpert; David M Harris; Andrea D Eckhart; Patrick Most; Walter J Koch
Journal:  Circ Res       Date:  2010-09-02       Impact factor: 17.367

View more
  5 in total

Review 1.  Tumor Necrosis Factor-α in Heart Failure: an Updated Review.

Authors:  Sarah M Schumacher; Sathyamangla V Naga Prasad
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

2.  Therapeutic Apheresis in Metabolic Syndrome.

Authors:  V A Voinov
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2018-05

3.  Carvedilol Prevents Redox Inactivation of Cardiomyocyte Β1-Adrenergic Receptors.

Authors:  Misun Park; Susan F Steinberg
Journal:  JACC Basic Transl Sci       Date:  2018-08-28

4.  Transcriptomic Validation of the Protective Effects of Aqueous Bark Extract of Terminalia arjuna (Roxb.) on Isoproterenol-Induced Cardiac Hypertrophy in Rats.

Authors:  Gaurav Kumar; Nikhat Saleem; Santosh Kumar; Subir K Maulik; Sayeed Ahmad; Manish Sharma; Shyamal K Goswami
Journal:  Front Pharmacol       Date:  2019-12-10       Impact factor: 5.810

Review 5.  Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4.

Authors:  Zheng Xiao; Bin Kong; Hongjie Yang; Chang Dai; Jin Fang; Tianyou Qin; He Huang
Journal:  Front Cardiovasc Med       Date:  2020-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.